Cardlytics (CDLX) Tops Q4 EPS by 14c, Offers Q1 Guidance
Tweet
Share
E-mailGet Alerts CDLX Hot Sheet
Join SI Premium – FREE
Cardlytics (NASDAQ: CDLX) reported Q4 EPS of $0.18, $0.14 better than the analyst estimate of $0.04. Revenue for the quarter came in at $69.3 million versus the consensus estimate of $63.89 million.
GUIDANCE:
Cardlytics sees Q1 2020 revenue of $43.5-46.5 million vs $52.77 million expected.
| Q1 2020 Guidance | |
| Billings(1) | $64.0 - $69.0 |
| Revenue | $43.5 - $46.5 |
| Adjusted contribution(2) | $19.0 - $20.5 |
| Adjusted EBITDA(3) | ($4.5) - ($3.0) |
For earnings history and earnings-related data on Cardlytics (CDLX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
- RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
